Modulating BTK-dependent inflammatory signalling in microglia ConferenceMS Virtual 2020 TypePeer-reviewed article 25 November 2020 16:49
Masitinib: a first-in-class TKI as treatment of progressive MS TrialAB07002 ConferenceMS Virtual 2020 TypePeer-reviewed article 25 November 2020 16:49
Clinical features of a recently identified disease: GFAP autoimmunity ConferenceMS Virtual 2020 TypePeer-reviewed article 25 November 2020 16:45